Caseous mitral annular calcification (CMAC), sometimes called liquefaction necrosis of mitral annular calcification (MAC), is a rare variant of MAC, a chronic degenerative process that progresses with age.

The recent approval of lecanemab is a win for Alzheimer’s patients, but how can pharma ensure access?

Eli Lilly has pledged over $1m to improve cold chain capacity for insulin in low- to middle-income countries.

Travel to Poland to discover the factors driving its pharmerging status and access to medicine challenges.

The COVID-19 pandemic has been a huge challenge for the Greek National Health System. Real-time reverse transcription PCR (rtRT-PCR) remains the reference method for early diagnosis, contact tracing, and containment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Explore the key trends and themes industry experts predict will be in store for pharma over the next 12 months.

Treatments for cancer are continuously advancing, but pharma must also focus on supporting patients’ mental health.

This infographic explores how the pharmaceutical industry is attracting and supporting the future STEM workforce with DE&I initiatives.

While people with multiple sclerosis (MS) are not more likely to contract COVID-19, the incidences of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19-related complications may be higher for people with MS who have comorbidities or who are taking certain disease modifying therapies (DMT).